AAO-HNS GUIDELINES Bundle (free trial)

Rhinoplasty

American Academy of Otolaryngology-Head and Neck Surgery Foundation GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1012325

Contents of this Issue

Navigation

Page 7 of 17

8 Management Table 6. Summary of Key Action Statements (KAS) Statement Action Grade 1. Communicating expectations Clinicians should ask all patients seeking rhinoplasty about their motivations for surgery and their expectations for outcomes, should provide feedback as to whether those expectations are a realistic goal of surgery, and should document this discussion in the medical record. R-C 2. Comorbid Conditions Clinicians should assess rhinoplasty candidates for comorbid conditions that could modify, or contraindicate surgery that include obstructive sleep apnea, body dysmorphic disorder, bleeding disorders, or chronic use of topical vasoconstrictive intranasal drugs. R-C 3. Nasal airway obstruction e surgeon, or the surgeon's designee, should evaluate the rhinoplasty candidate for nasal airway obstruction during the preoperative assessment. R-C 4. Preoperative education e surgeon, or the surgeon's designee, should educate rhinoplasty candidates regarding what to expect aer surgery, how surgery might affect the ability to breathe through the nose, potential complications of surgery, and the possible need for future nasal surgery. R-C 5. Counseling for obstructive sleep apnea patients e clinician, or the clinician's designee, should counsel rhinoplasty candidates with documented obstructive sleep apnea (OSA) about the impact of surgery on nasal airway obstruction and how OSA might affect perioperative management. R-B 6. Managing pain and discomfort e surgeon, or the surgeon's designee, should educate rhinoplasty patients before surgery about strategies to manage discomfort aer surgery. R-C 7. Postoperative antibiotics When a surgeon, or surgeon's designee, chooses to administer perioperative antibiotics for rhinoplasty, they should not be routinely prescribed for a duration of >24 hours aer surgery. R-B (against) 8. Perioperative steroids e surgeon, or the surgeon's designee, may administer perioperative systemic steroids to the rhinoplasty patient. O-B 9. Nasal packing Surgeons should NOT routinely place packing in the nasal cavity of rhinoplasty (with or without septoplasty) patients at the conclusion of surgery. R-C 10. Outcome assessment Clinicians should document patient satisfaction with their nasal appearance and with their nasal function at a minimum of 12 months aer rhinoplasty. R-C

Articles in this issue

Archives of this issue

view archives of AAO-HNS GUIDELINES Bundle (free trial) - Rhinoplasty